Dr. Milo Malanga on what are cyclodextrins?
🔎 In this video, Milo Malanga from CarboHyde explains how cyclodextrins are being harnessed to support the safe and effective delivery of RNA-based therapies for Crohn’s disease within the GENEGUT project.
🔬 GENEGUT is developing a first-in-class oral RNA-based therapy to target intestinal inflammation at its source, and cyclodextrins are playing an essential role.
The RNA delivery will be enabled by a combination approach using novel Biomaterials, including patented amphiphilic cyclodextrins and amino polyesters, are designed to protect and carry RNA through the gastrointestinal tract by forming nanoparticles.
